MedTrace Logo

The Long COVID-19 Wearable Device Study

NCT05741112 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100500

Last updated 2025-05-11

No results posted yet for this study

Summary

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Conditions

  • Long COVID
  • Postural Orthostatic Tachycardia Syndrome
  • Dysautonomia
  • Myalgic Encephalomyelitis
  • Chronic Fatigue Syndrome
  • Long Covid19

Interventions

DEVICE

Wearable device

The treatment group will receive their wearable device and the enhanced education at the start of the study. Their outcomes will be compared with the control group who will receive at 3 months.

Sponsors & Collaborators

  • Scripps Translational Science Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-16
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741112 on ClinicalTrials.gov